SEC INVESTIGATING ENDOCARE STOCK OPTION PRACTICES, FIRM REPORTS

Endocare Aug. 8 announced its second-quarter and six-month results, including an announcement of an SEC investigation of irregular stock option practices at the firm. The company also provided an update on an ongoing SEC and DOJ investigation of the firm's accounting practices.
Endocare